Figure1 (Figure1)
This is a clinical study that investigates the plasma concentrations of Nabumetone Active Metabolite (BMNA) at steady-state after administering Nabumetone once-daily. The study involved 31 participants who received Nabumetone 1000 mg and 12 participants who received Nabumetone 2000 mg. The graph in the text shows the concentration of BMNA at different hours after dosing.*